| |
AstaFactor® health survey: too good to be true?
Please email me the details of these survey results Yes, I have read the disclaimer. Safety study testimonialsBefore the commercial launch of The AstaFactor®, Mera Pharmaceuticals conducted a human clinical safety study to determine safe dosage of daily intake of astaxanthin products manufactured with Mera Pharmaceuticals’ proprietary technology. After completion of this safety study, scientists at Mera Pharmaceuticals, Inc., conducted a survey among the participants to collect their observations and comments regarding the study. There were many particularly encouraging comments and testimonials. Below is a selection of some of those positive observations from the volunteers. Jane, age 39, does aerobic training and weight training twice a week: 2 "I felt more alert, but naturally", "I feel more energetic, not so lethargic", "I caught a cold a few days after I started, but I recovered quickly. I am not sure if it had anything to do with the product". Oliver, age 31, undergoes 14 hrs of triathlon training in a week. 3 Did you feel any positive effect on your general well-being and physical activity? Mark, age 43. 3 Every week bikes 50 to 80 miles, swims 2 to 3 miles, and does sits-ups and push-ups. Mark observed "a faster recovery after exercise". Paulette, age 36, walks and rides her bike 2 to 3 times a week. 2 "I felt more energy in my general well-being and physical activity". "I felt like doing more activities while taking this product". "I felt generally better while using this product, although, it took about a week before I noticed any change". Ty, age 38, averages 160 miles running per week. 3 Did you feel a positive effect on your general well-being and physical activity? "I felt my recovery from work-outs was pretty quick, after taking them". On your overall health? "When recovery is quick, your overall health seems to be better". Pat, age 36. 3 Noticed an "improved awareness and general well-being". Noticed "positive effects on his vision": "Charts were easier to read after one week." Lynn, age 49. 2 "When (twice) I should have had my usual allergic reaction (sneezing, congestion, etc…) from dust when cleaning (moving heavy dust present), nothing happened." Marlyne, age 41, runs 3.7 miles 3 times per week. 3 Did you feel any positive effect in your physical activity? "Yes, I ran 3.7 miles 3 times per week and felt good". Angelita, age 47. 3 Did you feel a positive effect on your general well-being and physical activity? "Yes I felt more energy, more alert". Deborah, age 41, jogs and walks briskly. 3 Did you feel any positive effect on your general well being? "Yes, I felt good", in your state of mind "I seemed more alert in the morning". In addition to comments on how they felt during the study, Mera Pharmaceuticals received encouraging positive feedback from most volunteers on the conditions of the safety study. All respondents to the post-study inquiry replied that they were satisfied with the organization of the study, and all but one felt they had been well informed on the conditions and purpose of the study. Some of the comments that came back were: "Outstanding amount of information", "I think you did a very good job", "I can't think of anything that could have been done better" In terms of adverse effects, several participants observed reddened stools, which did not always last throughout the study. This is a benign condition: reddening of the stool represents passage of some of the astaxanthin pigment (red in color) through the digestive tract in normal stool. Because astaxanthin has strong pigmenting concentrations, even very minute concentrations can cause this discoloration. No other significant adverse effects were identified, even in the intervention group taking nearly 4 times the recommended dose of astaxanthin (19 mg/day). 1 Before finalizing the astaxanthin dose to be used in The AstaFactor®, Mera Pharmaceuticals conducted a clinical study to determine safety levels of astaxanthin and algal biomass produced with Mera Pharmaceuticals technology. Participants received doses of 4 or 19 mg astaxanthin per day for 29 days. After the study was completed, a large number of the volunteers who participated in the study provided Mera Pharmaceuticals with additional personal observations and comments on their experiences while taking astaxanthin during the study. In the above selection, several comments support previous findings with astaxanthin in healthy human volunteers. Mera Pharmaceuticals will further investigate some of these potential benefits of astaxanthin relating to health and physical activity. Individuals made these observations from a small population sample in a study that had been designed to determine safety of astaxanthin, not its efficacy. Furthermore, these individual statements may not completely represent the opinions of the authors, nor should they be considered necessarily representative of the whole population sample. Mera Pharmaceuticals intends to conduct further research to confirm the benefits of astaxanthin suggested by this study. Mera Pharmaceuticals welcomes such testimonials, which provide information from patients and consumers on the effects observed while taking astaxanthin. Such comments may help form the basis for future research into astaxanthin and human health. As a result, we invite future users of The AstaFactor®to email, mail, or fax to us their comments and observations they experience while taking The AstaFactor®. 2 These volunteers belonged to the group taking 4 mg astaxanthin daily.3 These volunteers were taking 19 mg astaxanthin daily. Contact Information:Email: info@astafactor.com Disclaimer:These survey results and testimonials will aid Mera Pharmaceuticals in continuing clinical research needed to support product efficacy. They represent the observations and opinions of the respondents. Effects of AstaFactor® may vary with individuals. AstaFactor® is a nutritional supplement, not a medicine. As with any supplement, prior consultation with your physician is recommended before taking The AstaFactor®. This product is not approved to diagnose, treat, cure, or improve any disease. No statement is intended or should be construed as a recommendation to infringe any existing patent. Unauthorized use of the survey and testimonials is prohibited. Comments in this document have not been reviewed by the FDA.Back to top of page Copyright © 2004,2005,2006,2007 by Mera Pharmaceuticals, Inc. All rights reserved. Any unauthorized copying, distribution, or adaptation is strictly prohibited. |